Review of European Guidelines on Palliative Sedation: A Foundation for the Updating of the European Association for Palliative Care Framework.


Journal

Journal of palliative medicine
ISSN: 1557-7740
Titre abrégé: J Palliat Med
Pays: United States
ID NLM: 9808462

Informations de publication

Date de publication:
11 2022
Historique:
pubmed: 19 7 2022
medline: 4 11 2022
entrez: 18 7 2022
Statut: ppublish

Résumé

In 2009, the European Association for Palliative Care (EAPC) developed a framework on palliative sedation, acknowledging this practice as an important and ethically acceptable intervention of last resort for terminally ill patients experiencing refractory symptoms. Before and after that, other guidelines on palliative sedation have been developed in Europe with variations in terminology and concepts. As part of the Palliative Sedation project (Horizon 2020 Funding No. 825700), a revision of the EAPC framework is planned. The aim of this article is to analyze the most frequently used palliative sedation guidelines as reported by experts from eight European countries to inform the discussion of the new framework. The three most reported documents per country were identified through an online survey among 124 clinical experts in December 2019. Those meeting guideline criteria were selected. Their content was assessed against the EAPC framework on palliative sedation. The quality of their methodology was evaluated with the Appraisal Guideline Research and Evaluation (AGREE) II instrument. Nine guidelines were included. All recognize palliative sedation as a last-resort treatment for refractory symptoms, but the criterion of refractoriness remains a matter of debate. Most guidelines recognize psychological or existential distress as (part of) an indication and some make specific recommendations for such cases. All agree that the assessment should be multiprofessional, but they diverge on the expertise required by the attending physician/team. Regarding decisions on hydration and nutrition, it is proposed that these should be independent of those for palliative sedation, but there is no clear consensus on the decision-making process. Several weaknesses were highlighted, particularly in areas of rigor of development and applicability. The identified points of debate and methodological weaknesses should be considered in any update or revision of the guidelines analyzed to improve the quality of their content and the applicability of their recommendations.

Identifiants

pubmed: 35849746
doi: 10.1089/jpm.2021.0646
doi:

Substances chimiques

Hypnotics and Sedatives 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1721-1731

Auteurs

Séverine M Surges (SM)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.

Eduardo Garralda (E)

ATLANTES Global Palliative Care Observatory, Institute for Culture and Society, University of Navarra, Pamplona, Spain.
IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.

Birgit Jaspers (B)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.
Department of Palliative Medicine, University Medicine Goettingen, Goettingen, Germany.

Holger Brunsch (H)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.

Maaike Rijpstra (M)

Department of Anaesthesiology, Pain and Palliative Medicine, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands.

Jeroen Hasselaar (J)

Department of Anaesthesiology, Pain and Palliative Medicine, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands.

Michaël Van der Elst (M)

Laboratory of Experimental Radiotherapy, UH & KU Leuven, Leuven, Belgium.

Johan Menten (J)

Laboratory of Experimental Radiotherapy, UH & KU Leuven, Leuven, Belgium.

Ágnes Csikós (Á)

Department of Primary Health Care, Department of Hospice-Palliative Care, University of Pecs Medical School, Pecs, Hungary.

Sebastiano Mercadante (S)

Main Regional Centre for Pain Relief and Palliative/Supportive Care, La Maddalena Cancer Centre, Palermo, Italy.

Daniela Mosoiu (D)

Medical Faculty, Transilvania University, Brasov, Brasov, Romania.
Education and National Development Department, Hospice Casa Sperantei, Brasov, Brasov, Romania.

Sheila Payne (S)

International Observatory on End-of-Life Care, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom.

Carlos Centeno (C)

ATLANTES Global Palliative Care Observatory, Institute for Culture and Society, University of Navarra, Pamplona, Spain.
IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.

Lukas Radbruch (L)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH